InsiderTrades.com logo
Tina Marriott net worth and biography
  • Phone
  • Email
  • Website

Tina Marriott Biography and Net Worth

President & COO of Recursion Pharmaceuticals

Tina Marriott is the President and Chief Operating Officer at Recursion, a clinical-stage biotechnology company industrializing drug discovery by decoding biology. She has built a career at the intersection of bioengineering and mission-driven businesses seeking to improve lives. Ms. Marriott is a 20+ year veteran of the biopharmaceutical industry; prior to joining Recursion she held senior leadership roles at Genentech, Roche and Achaogen. She has a unique ability to solve complex organizational challenges while also building and empowering exceptional leaders and teams to solve problems and drive innovation. Since Ms. Marriott joined Recursion as COO in 2018, the company has significantly scaled its size and capabilities.

Ms. Marriott serves as board chair for antimicrobial company Revagenix, and serves on advisory boards for the Utah System of Higher Education Deep Technology Initiative and Colorado State University’s College of Engineering.  Ms. Marriott is an advocate for advancing women in engineering and business, and has been recognized as a CSU Distinguished Alumni, Healthcare Businesswomen’s Association Rising Star, and a Women Tech Awards winner. She holds a B.S. in Chemical Engineering from Colorado State University.

What is Tina Marriott's net worth?

The estimated net worth of Tina Marriott is at least $3.29 million as of October 24th, 2024. Ms. Marriott owns 521,138 shares of Recursion Pharmaceuticals stock worth more than $3,290,986 as of March 26th. This net worth estimate does not reflect any other assets that Ms. Marriott may own. Additionally, Ms. Marriott receives a salary of $702,240.00 as President & COO at Recursion Pharmaceuticals. Learn More about Tina Marriott's net worth.

How old is Tina Marriott?

Ms. Marriott is currently 49 years old. There are 5 older executives and no younger executives at Recursion Pharmaceuticals. The oldest executive at Recursion Pharmaceuticals is Dr. David J. Mauro M.D., Ph.D., Chief Medical Officer, who is 59 years old. Learn More on Tina Marriott's age.

What is Tina Marriott's salary?

As the President & COO of Recursion Pharmaceuticals, Inc., Ms. Marriott earns $702,240.00 per year. The highest earning executive at Recursion Pharmaceuticals is Dr. Christopher C. Gibson Ph.D., Co-Founder, CEO & Director, who commands a salary of $806,720.00 per year. Learn More on Tina Marriott's salary.

How do I contact Tina Marriott?

The corporate mailing address for Ms. Marriott and other Recursion Pharmaceuticals executives is 41S RIO GRANDE STREET, SALT LAKE CITY UT, 84101. Recursion Pharmaceuticals can also be reached via phone at 385-269-0203 and via email at investorrelations@recursion.com. Learn More on Tina Marriott's contact information.

Has Tina Marriott been buying or selling shares of Recursion Pharmaceuticals?

Tina Marriott has not been actively trading shares of Recursion Pharmaceuticals during the past quarter. Most recently, Tina Marriott sold 6,000 shares of the business's stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $6.31, for a transaction totalling $37,860.00. Following the completion of the sale, the chief operating officer now directly owns 521,138 shares of the company's stock, valued at $3,288,380.78. Learn More on Tina Marriott's trading history.

Who are Recursion Pharmaceuticals' active insiders?

Recursion Pharmaceuticals' insider roster includes Blake Borgeson (Director), Terry-Ann Burrell (Director), Zavain Dar (Director), Christopher Gibson (CEO), Tina Larson (COO), Dean Li (Director), Tina Marriott (President & COO), Michael Secora (CFO), and Shafique Virani (Chief Corporate Development Officer). Learn More on Recursion Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Recursion Pharmaceuticals?

In the last year, insiders at the sold shares 38 times. They sold a total of 632,276 shares worth more than $4,877,731.94. The most recent insider tranaction occured on November, 13th when CFO Michael Secora sold 15,000 shares worth more than $114,900.00. Insiders at Recursion Pharmaceuticals own 15.8% of the company. Learn More about insider trades at Recursion Pharmaceuticals.

Information on this page was last updated on 11/13/2024.

Tina Marriott Insider Trading History at Recursion Pharmaceuticals

See Full Table

Tina Marriott Buying and Selling Activity at Recursion Pharmaceuticals

This chart shows Tina Marriott's buying and selling at Recursion Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k-$100k$0$100k$200kTotal Insider BuyingTotal Insider Selling

Recursion Pharmaceuticals Company Overview

Recursion Pharmaceuticals logo
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $6.17
Low: $6.08
High: $6.54

50 Day Range

MA: $7.47
Low: $5.94
High: $10.87

2 Week Range

Now: $6.17
Low: $5.60
High: $12.36

Volume

14,903,297 shs

Average Volume

10,594,744 shs

Market Capitalization

$2.48 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.85